FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : FDA THRESHOLD: LOWER-RISK BIOTECH INVESTING

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edscharp who wrote (11)	9/28/1999 9:47:00 PM
From: LLCF	Read Replies (1) of 75

<I think it's fair to say that most of the 2nd and 3rd tier biotechs are excluded from the "lower-risk" category. By and large these are companies that are engaged in P1 and/or early P2 trials. > I agree with the first part of your statement, but I think 2nd tier is higher on the vine than you're making out... there are 2nd tier companies with products. Great idea for a thread though... even if it's simply to talk about ongoing P3 trials and upcoming FDA decisions! DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next